Condition: Chemotherapy-Associated Paronychia · Sponsor: Veloce BioPharma LLC
Paronychia is inflammation of the skin surrounding the nail that leads to secondary infection. Iatrogenic paronychia has been clearly associated with cancer chemotherapies. This phase-2 trial is a dose finding study and will evaluate topical VBP-926 solution against a vehicle control.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Compassionate Cancer Care | Fountain Valley, California, United States | — |
| Northwestern University Department of Dermatology | Chicago, Illinois, United States | — |
| Washington University | St Louis, Missouri, United States | — |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | — |
| Montefiore Einstein Center for Cancer Care | The Bronx, New York, United States | — |
| Oncology Specialists of Charlotte | Charlotte, North Carolina, United States | — |
| Ohio State University | Columbus, Ohio, United States | — |
| Bryn Mawr Skin & Cancer Institute | Bryn Mawr, Pennsylvania, United States | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03207906